Video

CURE's Top Stories: January 2020

Take a look back at the top five CURE® stories for January 2020.

Here are the top five CURE® stories for January 2020.

5. Immunotherapy Vaccine Under Investigation

A new medication that aims to treat glioblastoma by using a patient’s own immune system will soon be available via a clinical trial this spring, according to researchers. Learn more in this story.

4. A Mother-Daughter Duo Believes in Hope

In this episode of the “CURE Talks Cancer” podcast, we spoke with breast cancer survivor Felicia Robinson, who recently wrote a book with her daughter on their personal experiences with a life-changing diagnosis.

3. The Falling, Wandering and Crashing of Treatment Side Effects

The bashing, the twitching, the gripping - here, CURE contributor Sherry Hanson explores the various neuropathy-related side effects she’s experienced as a result of her treatment for ovarian cancer.

2. Menopausal Hormone Therapy and Cancer

Women who took estrogen alone experienced decreased rates of breast cancer and death from the disease even after they stopped taking the therapy, when compared to women who took estrogen with progestin. Take a closer look at the data from the San Antonio Breast Cancer Symposium in this piece.

1. Cognitive Dysfunction After Cancer

How do you heal your mind when faced with cognitive impairment after cancer treatment? Take a closer look at the new challenges one woman faces in the aftermath of the disease in this story.

As always, thanks for reading!

Related Videos
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Related Content